NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/14/2025
Back to search
Official data from USPTO
MEGALLOLINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MEGALLOLINE
ST13
US500000079390167Class
1, 5, 42
Filing
79390167
Registration
7646753
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
04/03/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
11/07/2023
Registration date
01/14/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/14/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
SANTOMARTINO, MARTHA L
Law office
M30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
T. T. (pessoa física)
Representatives
Rebeccah Gan Muncy, Geissler, Olds & Lowe, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Stem cells for research; stem cells for scientific purposes; nutrition agentscell culture reagents for scientific and research use for processing living cells other than for medical purposes; cell culture media other than for medical and veterinary purposes
Class 5
Pharmaceutical products for the treatment of Parkinson's disease and neurodegenerative diseasesheart failurediabetesNon-Alcoholic Steatohepatitis and acute liver failureAge-related macular degeneration and limbal stem cells deficienciestraumatic injury and skin burnsspinal cord injuriesHuntington diseaseamyotrophic lateral sclerosisAlzheimer's diseasestrokeburnscancerosteoarthritisMultiple SclerosisRadiation Induced Intestinal InjuryInflammatory Bowel DiseaseLiver DiseaseDuchenne Muscular DystrophyBone DiseaseRenal DiseaseChronic WoundsGraft-Versus-Host DiseaseSepsis and Respiratory diseasesfunctional microtissues that facilitate transplantation and graft integration; pharmaceutical preparations for the treatment of Parkinson's disease and neurodegenerative diseasesheart failurediabetesNon-Alcoholic Steatohepatitis and acute liver failureAge-related macular degeneration and limbal stem cells deficienciestraumatic injury and skin burnsspinal cord injuriesHuntington diseaseamyotrophic lateral sclerosisAlzheimer's diseasestrokeburnscancerosteoarthritisMultiple SclerosisRadiation Induced Intestinal InjuryInflammatory Bowel DiseaseLiver DiseaseDuchenne Muscular DystrophyBone DiseaseRenal DiseaseChronic WoundsGraft-Versus-Host DiseaseSepsis and Respiratory diseasesfunctional microtissues that facilitate transplantation and graft integration; stem cells for medical or veterinary use; pluripotent stem cells for medical use intended for cell and gene therapies; cultures of cell media for medical and veterinary use; surgical implants comprised of living tissues obtained from stem cells
Class 42
Laboratory research in the field of biotechnology; scientific research on stem cells; scientific research on the production of pluripotent stem cells by encapsulation; research and development in the field of stem cellscell and gene therapy and biotechnology; pharmaceutical research and development; scientific laboratory services; providing information with respect to scientific research in the field of stem cellscell and gene therapy and biotechnology
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/14/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/26/2024
PUBO
PUBLISHED FOR OPPOSITION
11/26/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/30/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/29/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/28/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/28/2024
RFNT
REFUSAL PROCESSED BY IB
07/21/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/28/2024
RFRR
REFUSAL PROCESSED BY MPU
06/28/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/16/2024
CNRT
NON-FINAL ACTION WRITTEN
06/15/2024
DOCK
ASSIGNED TO EXAMINER
06/15/2024
MAFR
APPLICATION FILING RECEIPT MAILED
02/27/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/23/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/22/2024
Continuous trademark protection
Get notified about every new filing that threatens MEGALLOLINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.